Chemotherapy and heart failure

Authors

DOI:

https://doi.org/10.25250/thescbr.brk780

Keywords:

Anthracycline, Heart Failure, Breast Cancer, Chemotherapy

Abstract

Patients with a diagnosis of breast cancer or lymphoma who received chemotherapy treatment might be at risk of long-term side effects. We evaluated the association between a type of chemotherapy, called anthracyclines, and the risk of developing heart failure in patients with cancer. In this study, patients treated with anthracycline were more likely to have heart failure compared to controls.

Author Biographies

Hector Villarraga, Mayo Clinic

Associate Professor

Mariana Garcia Arango

Associate Professor

Original article reference

Larsen CM, Garcia Arango M, Dasari H, Arciniegas Calle M, Adjei E, Rico Mesa J, Scott CG, Thompson CA, Cerhan JR, Haddad TC, Goetz MP, Herrmann J, Villarraga HR. Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010. JAMA Netw Open. 2023 Feb 1;6(2):e2254669. doi: 10.1001/jamanetworkopen.2022.54669. Erratum in: JAMA Netw Open. 2023 Mar 1;6(3):e234015. PMID: 36735254; PMCID: PMC9898820.

Downloads

  • URL

Published

2024-03-26

Issue

Vol. 10 No. 1 (2024): TheScienceBreaker

Section

Health & Physiology

License

Some rights reserved 2023 Hector Villarraga, Mariana Garcia Arango

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.